Legacy Wealth Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Legacy Wealth Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$62.39 - $113.8 $10,419 - $19,004	-167 Reduced 4.91%	3,231 $367,000
Q3 2022 Oct 14, 2022	SELL	$58.92 - $84.67 $1,649 - $2,370	-28 Reduced 0.82%	3,398 $210,000
Q2 2022 Jul 19, 2022	BUY	$79.4 - $116.36 $238 - $349	3 Added 0.09%	3,426 $273,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $3,197 - $4,062	37 Added 1.09%	3,423 $360,000
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $9,264 - $11,271	-94 Reduced 2.7%	3,386 $365,000
Q3 2021 Oct 19, 2021	SELL	$91.91 - $110.37 $8,179 - $9,822	-89 Reduced 2.49%	3,480 $381,000
Q2 2021 Jul 14, 2021	SELL	$86.24 - $95.92 $18,369 - $20,430	-213 Reduced 5.63%	3,569 $334,000
Q1 2021 Apr 20, 2021	SELL	$71.83 - $95.48 $2,083 - $2,768	-29 Reduced 0.76%	3,782 $348,000
Q4 2020 Mar 25, 2021	BUY	$67.0 - $84.39 $255,337 - $321,610	3,811 New	3,811 $279,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.